SVRA
Savara Inc.$5.07-0.10 (-1.84%)Prev Close$5.16·MCap$1.01B·P/E—·Vol490.9K·Yield—
▲
Buys (12M)
2
$119.4K
▼
Sells (12M)
1
$121.2K
◆
Net Activity
Net Seller
$1.8K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Savara Inc. (SVRA) has been mixed between buying and selling, with 2 insider purchases totaling $119.4K and 1 insider sale totaling $121.2K. The most recent insider transaction was by RAMSAY DAVID A, who sold $121.2K worth of shares on Dec 19, 2025. Savara Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.01B.
SVRA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | RAMSAY DAVID A | Sell | 20,000 | $6.06 | $121.2K | 2,533,642 | |
| Jun 23, 2025 | Hawkins Richard J | Buy | 48,225 | $2.04 | $98.6K | 115,466+72% | |
| Jun 2, 2025 | McCracken Joseph S | Buy | 10,000 | $2.08 | $20.8K | 260,837 | |
| Apr 1, 2025 | RAMSAY DAVID A | Buy | 150,000 | $2.78 | $416.3K | 2,513,642 | |
| Dec 16, 2024 | Hawkins Richard J | Sell | 8,000 | $3.32 | $26.6K | 67,241 | |
| Dec 16, 2024 | Lowrance David L | Chief Financial Officer | Sell | 25,000 | $3.33 | $83.3K | 381,005 |
| Dec 16, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | 54,702 | $3.31 | $180.8K | 1,536,379 |
| Nov 20, 2024 | McCracken Joseph S | Buy | 20,000 | $2.95 | $59.1K | 210,837 | |
| Nov 18, 2024 | RAMSAY DAVID A | Buy | 100,000 | $2.88 | $287.6K | 2,323,642 | |
| Dec 29, 2023 | Elam Nevan C | Director | Sell | 93,843 | $4.71 | $442.3K | 22,500-81% |
| Dec 29, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | Sell | 10,000 | $4.71 | $47.1K | 342,355 |
| Dec 29, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | 84,000 | $4.71 | $395.9K | 1,302,674 |
| Jul 19, 2023 | Yang Rick | 10% Owner | Buy | 333,333 | $3.00 | $1000.0K | 24,471,264 |
| Jun 27, 2023 | Pratt Raymond Dennis | Chief Medical Officer | Buy | 6,500 | $2.93 | $19.0K | 160,000 |
| May 26, 2023 | RAMSAY DAVID A | Director | Buy | 100,000 | $2.59 | $258.5K | 2,201,142 |
| Jan 3, 2023 | RAMSAY DAVID A | Director | Buy | 36,000 | $1.54 | $55.6K | 2,101,142 |
| Dec 28, 2022 | RAMSAY DAVID A | Director | Buy | 19,000 | $1.45 | $27.6K | 2,065,142 |
| Dec 22, 2022 | Pratt Raymond Dennis | Chief Medical Officer | Buy | 3,500 | $1.54 | $5.4K | 153,500 |
| Dec 22, 2022 | RAMSAY DAVID A | Director | Buy | 45,000 | $1.48 | $66.4K | 2,046,142 |
| Dec 20, 2022 | RAMSAY DAVID A | Director | Buy | 54,890 | $1.50 | $82.1K | 2,001,142 |
| Nov 25, 2022 | RAMSAY DAVID A | Director | Buy | 20,105 | $1.43 | $28.7K | 1,946,252 |
| Nov 21, 2022 | RAMSAY DAVID A | Director | Buy | 50,005 | $1.37 | $68.4K | 1,926,147 |
| Sep 27, 2022 | RAMSAY DAVID A | Director | Buy | 135,000 | $1.39 | $187.1K | 1,876,142 |
| Sep 20, 2022 | RAMSAY DAVID A | Director | Buy | 8,000 | $1.45 | $11.6K | 1,741,142 |
| Sep 8, 2022 | RAMSAY DAVID A | Director | Buy | 32,000 | $1.40 | $44.7K | 1,733,142 |
| Sep 1, 2022 | RAMSAY DAVID A | Director | Buy | 100,000 | $1.42 | $141.9K | 1,701,142 |
| Jun 22, 2022 | RAMSAY DAVID A | Director | Buy | 100,000 | $1.38 | $138.4K | 1,601,142 |
| Dec 30, 2021 | RAMSAY DAVID A | Director | Buy | 50,000 | $1.28 | $64.0K | 1,501,142 |
| Dec 17, 2021 | Lowrance David L | CHIEF FINANCIAL OFFICER | Buy | 4,000 | $1.14 | $4.6K | 142,793 |
| Dec 17, 2021 | RAMSAY DAVID A | Director | Buy | 40,000 | $1.11 | $44.5K | 1,451,142 |
| Dec 13, 2021 | RAMSAY DAVID A | Director | Buy | 35,000 | $1.04 | $36.4K | 1,411,142 |
| Dec 9, 2021 | Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | Buy | 25,000 | $1.05 | $26.3K | 175,000 |
| Dec 9, 2021 | RAMSAY DAVID A | Director | Buy | 25,000 | $1.05 | $26.2K | 1,376,142 |
| Dec 8, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 6,500 | $1.06 | $6.9K | 383,672 |
| Dec 2, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $1.10 | $11.0K | 377,172 |
| Dec 2, 2021 | RAMSAY DAVID A | Director | Buy | 25,000 | $1.09 | $27.1K | 1,351,142 |
| Dec 1, 2021 | RAMSAY DAVID A | Director | Buy | 25,000 | $1.09 | $27.2K | 1,326,142 |
| Nov 22, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 22,150 | $1.10 | $24.4K | 367,172 |
| Nov 22, 2021 | RAMSAY DAVID A | Director | Buy | 200,000 | $1.08 | $215.4K | 1,301,142 |
| Sep 30, 2021 | RAMSAY DAVID A | Director | Buy | 137,052 | $1.29 | $176.4K | 1,101,142 |
| Aug 19, 2021 | RAMSAY DAVID A | Director | Buy | 97,290 | $1.18 | $115.2K | 964,090 |
| Aug 18, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 26,900 | $1.18 | $31.9K | 345,022 |
| May 24, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $1.63 | $16.3K | 318,122 |
| May 20, 2021 | RAMSAY DAVID A | Director | Buy | 5,003 | $1.58 | $7.9K | 866,800 |
| May 18, 2021 | RAMSAY DAVID A | Director | Buy | 50,000 | $1.62 | $81.1K | 861,797 |
| May 17, 2021 | Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | Sell | 50,000 | $1.56 | $77.9K | 150,000-25% |
| Apr 19, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 27,400 | $1.82 | $49.9K | 308,122 |
| Mar 22, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 24,100 | $2.07 | $49.9K | 280,722 |
| Mar 15, 2021 | Lowrance David L | CHIEF FINANCIAL OFFICER | Buy | 13,793 | $1.45 | $20.0K | 13,793 |
| Mar 15, 2021 | McCracken Joseph S | Director | Buy | 68,965 | $1.45 | $100.0K | 168,337+69% |
Showing 1–50 of 51
1 / 2
SVRA Insider Buying Activity
The following table shows recent insider purchases of Savara Inc. (SVRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 23, 2025 | Hawkins Richard J | Buy | 48,225 | $2.04 | $98.6K | 115,466+72% | |
| Jun 2, 2025 | McCracken Joseph S | Buy | 10,000 | $2.08 | $20.8K | 260,837 | |
| Apr 1, 2025 | RAMSAY DAVID A | Buy | 150,000 | $2.78 | $416.3K | 2,513,642 | |
| Nov 20, 2024 | McCracken Joseph S | Buy | 20,000 | $2.95 | $59.1K | 210,837 | |
| Nov 18, 2024 | RAMSAY DAVID A | Buy | 100,000 | $2.88 | $287.6K | 2,323,642 | |
| Jul 19, 2023 | Yang Rick | 10% Owner | Buy | 333,333 | $3.00 | $1000.0K | 24,471,264 |
| Jun 27, 2023 | Pratt Raymond Dennis | Chief Medical Officer | Buy | 6,500 | $2.93 | $19.0K | 160,000 |
| May 26, 2023 | RAMSAY DAVID A | Director | Buy | 100,000 | $2.59 | $258.5K | 2,201,142 |
| Jan 3, 2023 | RAMSAY DAVID A | Director | Buy | 36,000 | $1.54 | $55.6K | 2,101,142 |
| Dec 28, 2022 | RAMSAY DAVID A | Director | Buy | 19,000 | $1.45 | $27.6K | 2,065,142 |
| Dec 22, 2022 | Pratt Raymond Dennis | Chief Medical Officer | Buy | 3,500 | $1.54 | $5.4K | 153,500 |
| Dec 22, 2022 | RAMSAY DAVID A | Director | Buy | 45,000 | $1.48 | $66.4K | 2,046,142 |
| Dec 20, 2022 | RAMSAY DAVID A | Director | Buy | 54,890 | $1.50 | $82.1K | 2,001,142 |
| Nov 25, 2022 | RAMSAY DAVID A | Director | Buy | 20,105 | $1.43 | $28.7K | 1,946,252 |
| Nov 21, 2022 | RAMSAY DAVID A | Director | Buy | 50,005 | $1.37 | $68.4K | 1,926,147 |
| Sep 27, 2022 | RAMSAY DAVID A | Director | Buy | 135,000 | $1.39 | $187.1K | 1,876,142 |
| Sep 20, 2022 | RAMSAY DAVID A | Director | Buy | 8,000 | $1.45 | $11.6K | 1,741,142 |
| Sep 8, 2022 | RAMSAY DAVID A | Director | Buy | 32,000 | $1.40 | $44.7K | 1,733,142 |
| Sep 1, 2022 | RAMSAY DAVID A | Director | Buy | 100,000 | $1.42 | $141.9K | 1,701,142 |
| Jun 22, 2022 | RAMSAY DAVID A | Director | Buy | 100,000 | $1.38 | $138.4K | 1,601,142 |
| Dec 30, 2021 | RAMSAY DAVID A | Director | Buy | 50,000 | $1.28 | $64.0K | 1,501,142 |
| Dec 17, 2021 | Lowrance David L | CHIEF FINANCIAL OFFICER | Buy | 4,000 | $1.14 | $4.6K | 142,793 |
| Dec 17, 2021 | RAMSAY DAVID A | Director | Buy | 40,000 | $1.11 | $44.5K | 1,451,142 |
| Dec 13, 2021 | RAMSAY DAVID A | Director | Buy | 35,000 | $1.04 | $36.4K | 1,411,142 |
| Dec 9, 2021 | Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | Buy | 25,000 | $1.05 | $26.3K | 175,000 |
| Dec 9, 2021 | RAMSAY DAVID A | Director | Buy | 25,000 | $1.05 | $26.2K | 1,376,142 |
| Dec 8, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 6,500 | $1.06 | $6.9K | 383,672 |
| Dec 2, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $1.10 | $11.0K | 377,172 |
| Dec 2, 2021 | RAMSAY DAVID A | Director | Buy | 25,000 | $1.09 | $27.1K | 1,351,142 |
| Dec 1, 2021 | RAMSAY DAVID A | Director | Buy | 25,000 | $1.09 | $27.2K | 1,326,142 |
| Nov 22, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 22,150 | $1.10 | $24.4K | 367,172 |
| Nov 22, 2021 | RAMSAY DAVID A | Director | Buy | 200,000 | $1.08 | $215.4K | 1,301,142 |
| Sep 30, 2021 | RAMSAY DAVID A | Director | Buy | 137,052 | $1.29 | $176.4K | 1,101,142 |
| Aug 19, 2021 | RAMSAY DAVID A | Director | Buy | 97,290 | $1.18 | $115.2K | 964,090 |
| Aug 18, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 26,900 | $1.18 | $31.9K | 345,022 |
| May 24, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 10,000 | $1.63 | $16.3K | 318,122 |
| May 20, 2021 | RAMSAY DAVID A | Director | Buy | 5,003 | $1.58 | $7.9K | 866,800 |
| May 18, 2021 | RAMSAY DAVID A | Director | Buy | 50,000 | $1.62 | $81.1K | 861,797 |
| Apr 19, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 27,400 | $1.82 | $49.9K | 308,122 |
| Mar 22, 2021 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Buy | 24,100 | $2.07 | $49.9K | 280,722 |
| Mar 15, 2021 | Lowrance David L | CHIEF FINANCIAL OFFICER | Buy | 13,793 | $1.45 | $20.0K | 13,793 |
| Mar 15, 2021 | McCracken Joseph S | Director | Buy | 68,965 | $1.45 | $100.0K | 168,337+69% |
SVRA Insider Selling Activity
The following table shows recent insider sales of Savara Inc. (SVRA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | RAMSAY DAVID A | Sell | 20,000 | $6.06 | $121.2K | 2,533,642 | |
| Dec 16, 2024 | Hawkins Richard J | Sell | 8,000 | $3.32 | $26.6K | 67,241 | |
| Dec 16, 2024 | Lowrance David L | Chief Financial Officer | Sell | 25,000 | $3.33 | $83.3K | 381,005 |
| Dec 16, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | 54,702 | $3.31 | $180.8K | 1,536,379 |
| Dec 29, 2023 | Elam Nevan C | Director | Sell | 93,843 | $4.71 | $442.3K | 22,500-81% |
| Dec 29, 2023 | Lowrance David L | CHIEF FINANCIAL OFFICER | Sell | 10,000 | $4.71 | $47.1K | 342,355 |
| Dec 29, 2023 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | 84,000 | $4.71 | $395.9K | 1,302,674 |
| May 17, 2021 | Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | Sell | 50,000 | $1.56 | $77.9K | 150,000-25% |
SVRA Insiders
Similar Stocks to SVRA
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B